Trial intelligence / Profile preview

Treatment of endometrial hyperplasia

IRCT201506252624N18Phase 4Completed

Sponsor
Iran University of Medical Sciences
Start
Mar 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of metformin and megestrol in endometrial hyperplasia (EH) and Endometrial Hyperplasia Without Atypia (EH) (2 arms), sponsored by Iran University of Medical Sciences. Started Mar 2015; status: completed.

02

Drugs

metforminmegestrol
03

Conditions

endometrial hyperplasia (EH)Endometrial Hyperplasia Without Atypia (EH)

Beyond the preview

Go deeper on IRCT201506252624N18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201506252624N18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call